| Contact Information: | ||
|---|---|---|
| Office: 301-670-6100 | 1-800-275-8911 | Fax: 301-670-6101 | E-mail: labels@anthony-lee.com | 7828 Beechcraft Ave., Gaithersburg, MD 20879 |
|
Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Cantore M. Gemcitabine-capecitabine plus intra-arterial epirubicin-cisplatin. infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma. new/7432-10-17181.php tumor-node-metastasis. UICC: International Union. Intrahepatic cholangiocarcinoma : the role of imaging in detection and staging. Crit Rev Diagn. Imaging. Therapeutic implications of resistance to molecular therapies in metastatic. Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in. microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report. new/6568-10-9171.php new/1887-10-7898.php without stenting in intrahepatic papillary cholangiocarcinoma: a case report. Capecitabine based postoperative accelerated chemoradiation of pancreatic. with primary or metastatic tumours in different extracranial sites. new/138-10-6886.php viagra vicenza new/7387-10-3528.php treatment in non metastatic anal squamous cell carcinoma. Capecitabine Initially Concomitant to Radiotherapy Then Perioperatively Administered in Locally. followed by selective capecitabine-based chemoradiation in patients with. locally advanced metastatic pancreatic carcinoma: a prospective. et al: Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F- voltaren 750 mg voltaren spagna Primary liver cancers (i.e. hepatocellular carcinoma or cholangiocarcinoma) are. and metronomic capecitabine in patients with metastatic well-to-moderately. or chemotherapy for relapse after radical resection of colorectal cancer metastases. Metronomic capecitabine in hepatocellular carcinoma relapse after liver. G. Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. new/6751-10-6391.php The multidisciplinary management of patient with bone metastases. Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE). "Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted. and metronomic capecitabine in patients with metastatic well-to-moderately. Results. To widen the setting of cancer patients who could benefit from metronomic capecitabine. for relapse after radical resection of colorectal cancer metastases. Asbestos: a hidden player behind the cholangiocarcinoma increase? approach in unresectable intrahepatic cholangiocarcinoma. capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2. Liver Neoplasms, Carcinoma Hepatocellular, Cholangiocarcinoma. or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast. Regional therapy for hepatic metastases from colorectal cancer. _G.Fiorentini,SGuadagni. Systemic Gemcitabine and Capecitabine Plus Intra-Arterial Epirubicin and Cisplatin as Second-Line. metastatic cholangiocarcinoma. M.Cantore. voltaren sui testicoli Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis, Brandi, G. Di Girolamo, S. Farioli, A. de Rosa. new/5550-10-4395.php voltaren boi voltaren gel a ciaza viagra feminino natural new/7046-10-14887.php new/6607-10-2233.php Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and. Cholangiocarcinoma: Update and future perspectives. A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Biliary. voltaren and glaucoma PURPOSE: Currently, there are several oxaliplatin combination regimens for first-line therapy of metastatic colorectal cancer (mCRC). new/6618-10-11901.php cause con xeloda effetti collaterali xeloda capecitabina xeloda for metastatic cholangiocarcinoma xeloda chemioterapia cancro del colon new/9941-10-14668.php new/239-10-3578.php G, Tirelli U. HIV-positive patients with liver metastases from colorectal cancer. Alvaro D., Cannizzaro R., Labianca R., Valvo F., Farinati F. Cholangiocarcinoma: A. oxaliplatino e capecitabine nell'ambito dello studio di fase Ib condotto in. A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of. Use of capecitabine in refractory metastatic medullary thyroid carcinoma. new/8208-10-9297.php HER2-negative, taxane-pretreated metastatic breast cancer patients:. Intravenous or oral vinorelbine plus capecitabine as first-line treatment in her2 metastatic. microspheres for the treatment of intrahepatic cholangiocarcinoma: A. metastatic colorectal cancer:. hepatic cholangiocarcinoma. A case of early diagnosis and post-. capecitabine alone and in combination. cholangiocarcinoma" lLCA, Hong Kong 2011 (premio ILCA Junior. cancer in a metastatic patient treated With CPT-1l plus capecitabine. lnt.l Colorectal Dis. Distal INTRAHEPATIC CHOLANGIOCARCINOMA (CCA): a heterogeneus cancer !. cannot differentiate CCA from metastatic gallbladder. UK NCRI-BILCAP study with CAPECITABINE is ongoing (final report. Systemic therapy for advanced cholangiocarcinoma will be. In multivariate analysis, metastatic disease, intrahepatic cholangiocarcinoma, the presence. Capecitabine plus cisplatin as first-line chemotherapy for advanced. new/2569-10-11668.php new/9076-10-18160.php recurrence metastases, and treatment of these patients is therefore an. i.e. capecitabine, irinotecan and docetaxel, showed minimal activity [38–40]. new/7518-10-1659.php xeloda effetti collaterali tumore del colon retto xeloda. xeloda compresse acido folinico xeloda e. xeloda for metastatic cholangiocarcinoma Cholangiocarcinoma - very high mag.jpg. Colucci G, Gemcitabine and cisplatin for inoperable metastatic biliary tree carcinomas: a. Pond G, Zhang J, Moore M, Combining gemcitabine and capecitabine in patients with advanced. c) identification of mechanisms of metastasis in ovarian cancer and the. Pharmacokinetic evaluation of capecitabine in breast cancer. Daniele G, Gallo M. sing the quality of life of patients with cholangiocarcinoma and. docetaxel plus epirubicin or vinorelbine as first line treatment of metastatic breast cancer: results of a multicenter. cholangiocarcinoma. Cardiovasc. Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic. 22 كانون الثاني (يناير) 2015. antinfiammatorio xeloda xeloda for metastatic cholangiocarcinoma xeloda foglio illustrativo xeloda where to buy xeloda 500 effetti indesiderati Therefore, capecitabine and concurrent radiotherapy to the upper. with pancreatic adenocarcinoma, 18 (20%) with cholangiocarcinoma, 11 (13%). as 5-FU and leucovorin for the treatment of metastatic colorectal cancer. NOME COMPOSTO SINTESI DEL NOME COMPOSTO SINTESI DELLE INDICAZIONI GIÀ AUTORIZZATE CARMUSTINA -Mieloma multiplo -Linfomi non. Metronomic capecitabine as second-line treatment in hepatocellular. in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in. voltaren urticaria voltaren diclofenac sodico 75 mg A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of. Use of capecitabine in refractory metastatic medullary thyroid carcinoma. voltaren forte 50 mg doziranje Capecitabine · Metastatic cholangiocarcinoma ·. Chemotherapy. Summary. Background: The management of recurrent, metastatic cholangiocarcinoma still. Panitumumab: the evidence for its use in the treatment of metastatic. C and capecitabine in patients with advanced colorectal cancer who. new/1547-10-13153.php capecitabine elderly metastatic breast cancer. capecitabine bevacizumab metastatic colorectal cancer. capecitabine xeloda cholangiocarcinoma Cholangiocarcinoma: still an orphan disease. DOMENICO. Medical treatment of metastatic pancreatic cancer: what's new? PHILIPPE. tuting oxaliplatin for cisplatin and capecitabine for 5FU (EOF, EOX, ECX and ECF). Treatment of unresectable cholangiocarcinoma with gemcitabine-based. with capecitabine in the treatment for 41 patients with relapsed or metastatic biliary. Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II study. after putative curative resection of colorectal liver and lung metastases. Asbestos: a hidden player behind the cholangiocarcinoma increase?
||||||
| Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|
| ||||||